Daily FNArena News

FNArena is one of few remaining truly independent providers of financial markets analysis, financial commentary and business news in Australia. Our Daily Financial News is not based on ASX lodgements or corporate press releases, but more so on updated views, insights and responses from stockbrokers and other experts. FNArena is not aligned with any financial institution, hence the moniker “independent”. We have a long history of publishing out-of-consensus views and market analysis. Our quest is not to be bullish or bearish, but to correctly assess future trends.

Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | Technicals | Treasure Chest |

Latest Stories

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

11:29 AM - Australia

Macro concerns overshadowed ESG developments during the February reporting season, but there was plenty to report: decarbonisation continued apace; green commodities entered rocky water but other revenue-generating projects progressed; and regulators took aim

8:14 AM - ESG Focus

While coal prices have started to retreat after a strong rally, New Hope Corp’s capital expenditure plans should see the company boost production

Mar 23 2023 - Australia

In newly released research, two brokers express a preference for Stanmore Resources over Coronado Global Resources

Mar 22 2023 - Commodities

Previous Stories

No Enthusiasm To Combine ACL & Healius

Mar 21 2023 - Australia

A takeover bid for Healius by Australian Clinical Labs has been greeted with very little enthusiasm, if any

ASX200: Oversold?

Mar 21 2023 - Technicals

Michael Gable of Fairmont Equities suggests the technicals are indicating the ASX200 has become oversold, suggesting a bounce is possible

Telix Pharmaceuticals’ Pipeline Full Of Promise

Mar 21 2023 - Small Caps

Following FY22 results for Telix Pharmaceuticals brokers remain Buy-rated in light of an extensive pipeline of new products under development

Macquarie’s Growing Opportunity In The Americas

Mar 20 2023 - Australia

After a recent tour of Macquarie Group’s operations in the Americas, brokers highlight the growing opportunity in the region

FNArena Corporate Results Monitor – 17-03-2023

Mar 17 2023 - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

FDA Approval Puts Rocket Under Neuren Shares

Mar 16 2023 - Small Caps

Amidst a sea of red, the Neuren share price has skyrocketed in recent days following a world first approval for the biotech’s treatment of Rett syndrome

Gold: Ready To Shine?

Mar 16 2023 - Technicals

The Chartist reports all signals are bullish for gold longer term, but in the nearer term some patience may be required

Dr Boreham’s Crucible: SDI

Mar 16 2023 - Small Caps

Tim Boreham gets his teeth into the opportunity ahead for listed dental products company SDI

Preventative Health In The Spotlight Post Covid

Mar 15 2023 - Australia

The post-covid world presents an opportunity for healthcare professionals to engage more deeply with preventative care, as Australians list healthcare advice as a top motivator for actively managing their health

Treasury Wine Targets Younger Consumers

Mar 15 2023 - Australia

Doubling down on lines aimed at a younger, more loyal, demographic, Treasury Wine Estates has unveiled its One by Penfolds collection as a gateway to premium offerings

Analyse The Market From A Different Angle